- $53.03bn
- $71.60bn
- $147.40bn
- 78
- 85
- 25
- 66
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 107,443 | 64,129 | 111,476 | 169,990 | 147,399 |
Cost of Revenue | |||||
Gross Profit | 11,753 | 6,422 | 9,374 | 20,058 | 19,313 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 105,079 | 69,947 | 112,530 | 157,440 | 139,502 |
Operating Profit | 2,364 | -5,818 | -1,054 | 12,550 | 7,897 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 4,178 | -4,964 | 1,740 | 14,639 | 9,469 |
Provision for Income Taxes | |||||
Net Income After Taxes | 3,419 | -3,714 | 1,594 | 11,391 | 7,239 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 3,076 | -3,975 | 1,317 | 11,024 | 7,015 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 3,074 | -3,983 | 1,306 | 11,024 | 7,015 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 8.92 | 0.366 | 6.12 | 18.8 | 15.8 |
Dividends per Share |